BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31828481)

  • 1. Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population.
    Manuel SL; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Pavone ME
    J Assist Reprod Genet; 2020 Mar; 37(3):699-708. PubMed ID: 31828481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
    Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
    Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
    Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
    Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
    J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
    İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
    Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocyte cryopreservation for women with GATA2 deficiency.
    Zolton JR; Parikh TP; Hickstein DD; Holland SM; Hill MJ; DeCherney AH; Wolff EF
    J Assist Reprod Genet; 2018 Jul; 35(7):1201-1207. PubMed ID: 29532200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
    Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
    J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant.
    Lavery SA; Islam R; Hunt J; Carby A; Anderson RA
    Hum Reprod; 2016 Jul; 31(7):1501-7. PubMed ID: 27112701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility Preservation for Adolescent and Young Adult Transmen: A Case Series and Insights on Oocyte Cryopreservation.
    Barrett F; Shaw J; Blakemore JK; Fino ME
    Front Endocrinol (Lausanne); 2022; 13():873508. PubMed ID: 35685214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
    Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
    J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.